Pliant Therapeutics, Inc.
PLRX
$1.35
$0.042.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 44.92M | 53.75M | 57.68M | 59.31M | 59.06M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 146.37M | 186.22M | 219.86M | 234.91M | 228.37M |
| Operating Income | -146.37M | -186.22M | -219.86M | -234.91M | -228.37M |
| Income Before Tax | -149.34M | -175.50M | -206.96M | -219.52M | -210.30M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -149.34 | -175.50 | -206.96 | -219.52 | -210.30 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -149.34M | -175.50M | -206.96M | -219.52M | -210.30M |
| EBIT | -146.37M | -186.22M | -219.86M | -234.91M | -228.37M |
| EBITDA | -144.68M | -184.43M | -217.98M | -232.85M | -226.24M |
| EPS Basic | -2.43 | -2.87 | -3.39 | -3.61 | -3.47 |
| Normalized Basic EPS | -1.40 | -1.79 | -2.12 | -2.26 | -2.17 |
| EPS Diluted | -2.43 | -2.87 | -3.39 | -3.61 | -3.47 |
| Normalized Diluted EPS | -1.40 | -1.79 | -2.12 | -2.26 | -2.17 |
| Average Basic Shares Outstanding | 245.46M | 244.87M | 244.19M | 243.19M | 242.15M |
| Average Diluted Shares Outstanding | 245.46M | 244.87M | 244.19M | 243.19M | 242.15M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |